Atlas Trials

Safety, Efficacy of Eglandin® in Living Donor Liver Transplanted Patient (PROVISION)

Clinical trial NCT02350218 · UNKNOWN

Trial details

NCT number
NCT02350218
Sponsor
Asan Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Evidence of Liver Transplantation
Start date
2015-03-01
Primary completion
2018-12-01
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.